In 2015, researchers began noticing that a drug used to treat Type 2 diabetes, empagliflozin, came with the added benefit
Continue reading »
mypharmacynews.com
Home »
In 2015, researchers began noticing that a drug used to treat Type 2 diabetes, empagliflozin, came with the added benefit
Continue reading »General practice management of patients with cardiovascular disease (CVD) is “suboptimal,” with only 57% of patients with established CVD prescribed
Continue reading »Some restaurants and cafes are failing people with dementia because of loud noise, confusing signs and impatient staff, new research
Continue reading »Health minister accuses social media giants of failing to crack down on anti-vaxxers as official figures show up to one
Continue reading »An unexpected finding that links a structural heart protein to gene regulation following heart stress suggests potential new avenues for
Continue reading »Immune reactions are usually a good thing—the body’s way of eliminating harmful bacteria and other pathogens. But people also rely
Continue reading »